#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Greg Madison Email
CEO . shield therapeutics
Gateshead Quays,
Locationg*******@shieldtherapeutics.com
Primary EmailHow to contact Greg Madison
Join and see Greg's contact info for free!Current Roles
Employees:
92Revenue:
$18.5MAbout
Shield is a de-risked commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adults which has exclusive IP rights until the mid2030s. Feraccru® is commercialised in the European Union by Norgine BV and the US Food and Drug Administration (FDA) is currently considering a New Drug Application (NDA), with a PDUFA (Prescription Drug User Fee Act) date of 27 July 2019.shield therapeutics Address
Shield Therapeutics plcGateshead Quays, null